+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurovascular Embolization Devices - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • PDF Icon

    Report

  • 213 Pages
  • October 2019
  • Region: Global
  • Transparency Market Research
  • ID: 4911399
Neurovascular Embolization Devices (Neurology) Market - Scope of the Report

the report on the global neurovascular embolization devices (neurology) market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global neurovascular embolization devices (neurology) market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global neurovascular embolization devices (neurology) market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents, to understand the global neurovascular embolization devices (neurology) market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global neurovascular embolization devices (neurology) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global neurovascular embolization devices (neurology) market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global neurovascular embolization devices (neurology) market. The next section of the global neurovascular embolization devices (neurology) report highlights the USPs, which include the regulatory scenario, reimbursement scenario, key mergers & acquisitions, technological advancements, and key industry developments in the global neurovascular embolization devices (neurology) market.

The report delves into the competitive landscape of the global neurovascular embolization devices (neurology) market. Key players operating in the global neurovascular embolization devices (neurology) market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global neurovascular embolization devices (neurology) market profiled in this report.

Key Questions Answered in the Neurovascular Embolization Devices (Neurology) Market Report

  • What are the major drivers, restraints, opportunities in the market?
  • What are the revenue share projections of key segments in the global neurovascular embolization devices (neurology) market for the forecast period?
  • Which segment is likely to lead the neurovascular embolization devices (neurology) market in terms of revenue by 2027?
  • How are mergers & acquisitions among players widening the scope of the neuroendovascular embolization devices (neurology) market?
  • What is the market position of different companies operating in the global neurovascular embolization devices (neurology) market?
Research Objectives and Research Approach

The comprehensive report on the global neurovascular embolization devices (neurology) market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the global neurovascular embolization devices (neurology) market. It is followed by a market introduction, market dynamics, and an overview of the global neurovascular embolization devices (neurology) market, which includes an’s analysis of the market drivers, restraints, and trends affecting the growth of the global neurovascular embolization devices (neurology) market. Furthermore, to understand the Y-o-Y trends of the neurovascular embolization devices (neurology) market, a Y-o-Y analysis with elaborated insights on the same have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Regulatory Scenario
5.3. Reimbursement Scenario
5.4. Key Mergers & Acquisitions
5.5. Technological Advancements
6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
6.2.1. Embolization Coils
6.2.2. Liquid Embolic Systems
6.2.3. Flow Diversion Stents
6.2.4. Aneurysm Clips
6.2.5. Others
6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product
7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment
7.1. Introduction & Definition
7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
7.2.1. Ischemic Stroke Solution
7.2.2. Hemorrhagic Stroke Solution
7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment
8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication
8.1. Introduction
8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
8.2.1. Brain Aneurysms
8.2.2. Arteriovenous Malformation (AVM)
8.2.3. Others
8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication
9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User
9.1. Introduction
9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
9.2.1. Hospitals
9.2.2. Ambulatory Surgery Centers
9.2.3. Specialty Clinics
9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User
10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region
10.1. Introduction
10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region
11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
11.1. Introduction
11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
11.2.1. Embolization Coils
11.2.2. Liquid Embolic Systems
11.2.3. Flow Diversion Stents
11.2.4. Aneurysm Clips
11.2.5. Others
11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
11.3.1. Ischemic Stroke Solution
11.3.2. Hemorrhagic Stroke Solution
11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
11.4.1. Brain Aneurysms
11.4.2. Arteriovenous Malformation (AVM)
11.4.3. Others
11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
11.5.1. Hospitals
11.5.2. Ambulatory Surgery Centers
11.5.3. Specialty Clinics
11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Treatment
11.7.3. By Indication
11.7.4. By End User
11.7.5. By Country/Sub-region
12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
12.1. Introduction
12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
12.2.1. Embolization Coils
12.2.2. Liquid Embolic Systems
12.2.3. Flow Diversion Stents
12.2.4. Aneurysm Clips
12.2.5. Others
12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
12.3.1. Ischemic Stroke Solution
12.3.2. Hemorrhagic Stroke Solution
12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
12.4.1. Brain Aneurysms
12.4.2. Arteriovenous Malformation (AVM)
12.4.3. Others
12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
12.5.1. Hospitals
12.5.2. Ambulatory Surgery Centers
12.5.3. Specialty Clinics
12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Treatment
12.7.3. By Indication
12.7.4. By End User
12.7.5. By Country/Sub-region
13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
13.2.1. Embolization Coils
13.2.2. Liquid Embolic Systems
13.2.3. Flow Diversion Stents
13.2.4. Aneurysm Clips
13.2.5. Others
13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
13.3.1. Ischemic Stroke Solution
13.3.2. Hemorrhagic Stroke Solution
13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
13.4.1. Brain Aneurysms
13.4.2. Arteriovenous Malformation (AVM)
13.4.3. Others
13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
13.5.1. Hospitals
13.5.2. Ambulatory Surgery Centers
13.5.3. Specialty Clinics
13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Treatment
13.7.3. By Indication
13.7.4. By End User
13.7.5. By Country/Sub-region
14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
14.2.1. Embolization Coils
14.2.2. Liquid Embolic Systems
14.2.3. Flow Diversion Stents
14.2.4. Aneurysm Clips
14.2.5. Others
14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
14.3.1. Ischemic Stroke Solution
14.3.2. Hemorrhagic Stroke Solution
14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
14.4.1. Brain Aneurysms
14.4.2. Arteriovenous Malformation (AVM)
14.4.3. Others
14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
14.5.1. Hospitals
14.5.2. Ambulatory Surgery Centers
14.5.3. Specialty Clinics
14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Treatment
14.7.3. By Indication
14.7.4. By End User
14.7.5. By Country/Sub-region
15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
15.2.1. Embolization Coils
15.2.2. Liquid Embolic Systems
15.2.3. Flow Diversion Stents
15.2.4. Aneurysm Clips
15.2.5. Others
15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
15.3.1. Ischemic Stroke Solution
15.3.2. Hemorrhagic Stroke Solution
15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
15.4.1. Brain Aneurysms
15.4.2. Arteriovenous Malformation (AVM)
15.4.3. Others
15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
15.5.1. Hospitals
15.5.2. Ambulatory Surgery Centers
15.5.3. Specialty Clinics
15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Treatment
15.7.3. By Indication
15.7.4. By End User
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)
16.2. Company Profiles
16.2.1. Medtronic plc
16.2.1.1. Company Description
16.2.1.2. Business Overview
16.2.1.3. Financial Overview
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Stryker Corporation
16.2.2.1. Company Description
16.2.2.2. Business Overview
16.2.2.3. Financial Overview
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)
16.2.3.1. Company Description
16.2.3.2. Business Overview
16.2.3.3. Financial Overview
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. B.Braun Melsungen AG
16.2.4.1. Company Description
16.2.4.2. Business Overview
16.2.4.3. Financial Overview
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Penumbra, Inc.
16.2.5.1. Company Description
16.2.5.2. Business Overview
16.2.5.3. Financial Overview
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. Acandis GmbH
16.2.6.1. Company Description
16.2.6.2. Business Overview
16.2.6.3. Financial Overview
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. BALT EXTRUSION
16.2.7.1. Company Description
16.2.7.2. Business Overview
16.2.7.3. Financial Overview
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Terumo Medical Corporation
16.2.8.1. Company Description
16.2.8.2. Business Overview
16.2.8.3. Financial Overview
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Boston Scientific Corporation
16.2.9.1. Company Description
16.2.9.2. Business Overview
16.2.9.3. Financial Overview
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Spartan Micro, Inc.
16.2.10.1. Company Description
16.2.10.2. Business Overview
16.2.10.3. Financial Overview
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Medtronic plc
  • Stryker Corporation
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • B.Braun Melsungen AG
  • Penumbra, Inc.
  • Acandis GmbH
  • BALT EXTRUSION
  • Terumo Medical Corporation
  • Boston Scientific Corporation
  • Spartan Micro, Inc.